<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04923841</url>
  </required_header>
  <id_info>
    <org_study_id>R5032-18</org_study_id>
    <nct_id>NCT04923841</nct_id>
  </id_info>
  <brief_title>Myopia Control Using Bright Light Therapy and Myopic Defocus</brief_title>
  <official_title>Effectiveness of Bright Light Therapy, Myopic Defocus and the Combinations for Controlling Myopic Eye Growth in Schoolchildren: A Randomized Control Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Hong Kong Polytechnic University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>The University of Hong Kong</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>The Hong Kong Polytechnic University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to investigate the effect of bright light therapy, myopic&#xD;
      defocus, and the combination in myopia control in schoolchildren.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The present study is a multi-arm randomised clinical trial with a 24-month duration. Subjects&#xD;
      will be healthy Hong Kong Chinese schoolchildren with low to moderate myopia. The aims are to&#xD;
      determine the clinical effectiveness of bright light therapy on inhibiting myopia progression&#xD;
      in schoolchildren, and to determine whether combination therapy using bright light therapy&#xD;
      (BLT) and myopic defocus is more effective than monotherapy.&#xD;
&#xD;
      Study population Four hundred and fifty six Hong Kong Chinese children (152 in each of A.&#xD;
      Control group, B. BLT only group and C. BLT and Defocus Incorporated Multiple Segments (DIMS)&#xD;
      group) aged 7-12 years old will be recruited. They must not have had prior or current myopia&#xD;
      control treatment, have no ocular or systemic diseases/abnormalities that affect visual&#xD;
      function, refractive development or spectacle lens wear, and no previous intraocular or&#xD;
      corneal surgery. They must not have allergy to atropine.&#xD;
&#xD;
      The eligible subjects will be randomly assigned into one of the four groups. Their&#xD;
      cycloplegic refraction and axial length will be monitored every six months for 2 years. The&#xD;
      changes in refractive errors and axial length between groups will be compared.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 1, 2021</start_date>
  <completion_date type="Anticipated">August 30, 2025</completion_date>
  <primary_completion_date type="Anticipated">August 30, 2025</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cycloplegic Refraction Change in spherical equivalent refraction (SER)</measure>
    <time_frame>Baseline and 2 years</time_frame>
    <description>Change in cycloplegic SER (in diopter) will be measured using an open field autorefractor</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Axial length</measure>
    <time_frame>Baseline and 2 years</time_frame>
    <description>Axial length (mm) will be measured after cycloplegia using a non-contact optical biometer</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">456</enrollment>
  <condition>Myopia</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Subjects in control will receive single vision spectacle lenses and a placebo desk lamp</description>
  </arm_group>
  <arm_group>
    <arm_group_label>BLT monotherapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects in BLT monotherapy group will receive a high intensity light box for bright light therapy and single vision spectacle lenses</description>
  </arm_group>
  <arm_group>
    <arm_group_label>BLT and DIMS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects in BLT and DIMS group will receive a high intensity light box for bright light therapy and Defocus Incorporated Multiple Segments (DIMS) spectacle lenses</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>A high intensity light box and myopic defocus</intervention_name>
    <description>In this study, the effect of bright light given by a high intensity light box and its combination with myopic defocus will be given as interventions. Myopic defocus will be delivered by Defocus Incorporated Multiple Segments (DIMS) spectacle lenses.</description>
    <arm_group_label>BLT and DIMS</arm_group_label>
    <arm_group_label>BLT monotherapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Myopia of at least -0.75D (spherical equivalent) in both eyes&#xD;
&#xD;
          -  Age at enrolment: 7-12 year; Hong Kong Chinese&#xD;
&#xD;
          -  Astigmatism and anisometropia: 1.50D or less&#xD;
&#xD;
          -  Spectacle corrected monocular visual acuity (VA): 0.0 logMAR or better&#xD;
&#xD;
          -  Parents' understanding and acceptance of random allocation of grouping and masking&#xD;
&#xD;
          -  Able to wear the prescribed spectacle, put on eye drop and undergo light therapy&#xD;
             daily.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Eye disease or binocular vision problems (e.g., strabismus, amblyopia, oculomotor&#xD;
             nerve palsies, corneal disease, etc.)&#xD;
&#xD;
          -  Previous intraocular or corneal surgery&#xD;
&#xD;
          -  Systemic disease that may affect vision, vision development (e.g. endocrine, cardiac&#xD;
             and respiratory diseases, diabetes, Down syndrome, etc.)&#xD;
&#xD;
          -  Allergy to atropine&#xD;
&#xD;
          -  Previous gas permeable, soft bifocal, or orthokeratology contact lens wear or&#xD;
             bifocal/PAL/specific myopic control spectacle wear or use of atropine or pirenzepine&#xD;
             (longer than 1 month of wear)&#xD;
&#xD;
          -  Previous or current participation in myopia control studies&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>7 Years</minimum_age>
    <maximum_age>12 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chi Ho To, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>School of Optometry, The Hong Kong Polytechnic University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Dennis Yan-yin Tse, PhD</last_name>
    <phone>852-27666096</phone>
    <email>dennis.tse@polyu.edu.hk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Rachel Ka Man Chun, PhD</last_name>
    <phone>+852-27664224</phone>
    <email>rachel.chun@polyu.edu.hk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Centre for Myopia Research, The Hong Kong Polytechnic University and Department of Ophthalmology, The University of Hong Kong</name>
      <address>
        <city>Hong Kong</city>
        <zip>No postcode</zip>
        <country>Hong Kong</country>
      </address>
    </facility>
    <contact>
      <last_name>Dennis Yan-yin Tse, PhD</last_name>
      <phone>852-27666096</phone>
      <email>dennis.tse@polyu.edu.hk</email>
    </contact>
    <contact_backup>
      <last_name>Rachel Ka Man Chun, PhD</last_name>
      <phone>852-27664224</phone>
      <email>rachel.chun@polyu.edu.hk</email>
    </contact_backup>
    <investigator>
      <last_name>Wai Ching Lam, MD, FRCS(C)</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Hong Kong</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>June 7, 2021</study_first_submitted>
  <study_first_submitted_qc>June 7, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 11, 2021</study_first_posted>
  <last_update_submitted>August 30, 2021</last_update_submitted>
  <last_update_submitted_qc>August 30, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 2, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Myopia control</keyword>
  <keyword>Bright light</keyword>
  <keyword>Myopic defocus</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myopia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

